After Moderna stock surge of 177% on cancer drug breakthrough, here's what Wall Street thinks happens next — Live Feedhttps://www.live-feeds.com/feed/after-moderna-stock-surge-of-177-on-cancer-drug-breakthrough-here-s-what-wall-street-thinks-happens-nextContinuously updated, source-cited coverage. Moderna stock surges on cancer vaccine breakthroughhttps://www.live-feeds.com/feed/after-moderna-stock-surge-of-177-on-cancer-drug-breakthrough-here-s-what-wall-street-thinks-happens-nexthttps://www.live-feeds.com/feed/after-moderna-stock-surge-of-177-on-cancer-drug-breakthrough-here-s-what-wall-street-thinks-happens-next#u45926Fri, 21 Aug 2026 11:31:33 +0000Moderna's stock jumped 177% after announcing a breakthrough in its cancer vaccine trial, with the company's stock soaring to a 52-week high. The vaccine, developed in partnership with Merck, showed promise in a late-stage trial. This news has sparked speculation about the potential impact on the cancer treatment market.Why it mattersThe breakthrough has significant implications for the future of cancer care, with potential for a new wave of cancer vaccines. Moderna's mRNA technology has already been successful in COVID-19 vaccines, and this development could mark a major expansi